Profile
Dr. Lisbeth Tofte Hemmingsen
Dr. Lisbeth Tofte has founded the independent consultancy, Drug Safety Consult. The focus is on patient safety and QA services within pharmacovigilance, PASS and clinical development to biotech and pharmaceutical companies, academia and other institutions working in the health care business.
Dr. Lisbeth Tofte graduated from the Royal Dental University of Copenhagen to join the pharmaceutical industry shortly after.
As Group Director of International Quality Assurance at Nycomed, Dr. Lisbeth Tofte held the global responsibility for quality management of clinical development and pharmacovigilance and has been the driving force behind quality systems and concepts established to facilitate compliance with GCP, GVP, and PAS requirements both centrally and across affiliates.
With more than 30 years' experience, Dr. Lisbeth Tofte has held responsibility for international development programs in several therapeutic areas, working for GSK and NovoNordisk on novel chemical entities, biosynthetic drugs, and human plasma products.
Dr. Lisbeth Tofte: ISO examined lead auditor. -- Author of several articles and books. -- Correspondent on Clinical and QA Advisor.
Author of the following online training modules for Brookwood Academy: 3 x levels of Pharmacovigilance, 2 x Non Interventionel studies, 1 x Data Privacy. Ref: www.brookwoodtraining-online.net
Her guidebooks on Pharmacovigliance, Data Protection, and Computer Validation are issued by Canary Ltd